UditVani, Mumbai/Jamshedpur: Tata Steel Limited has unveiled a series of significant strategic decisions following its Board meeting held on Tuesday, signaling a strong push towards consolidation, global expansion, and diversification into healthcare.
Amalgamation with Neelachal Ispat Nigam Limited.
The Board approved a Scheme of Amalgamation involving Neelachal Ispat Nigam Limited, a wholly owned subsidiary, and Tata Steel along with their respective shareholders.
The merger will be carried out in accordance with Sections 230 to 232 of the Companies Act, 2013, and other applicable legal provisions.
The company stated that the amalgamation is subject to necessary approvals from regulatory authorities and stakeholders.
This move is expected to streamline operations, enhance operational efficiency, and strengthen Tata Steel’s domestic manufacturing footprint.
$2 Billion Investment in Overseas Subsidiary
In a major boost to its international operations, Tata Steel has approved an investment of up to USD 2 billion (approximately ₹18,488.10 crore) in T Steel Holdings Pte. Ltd.. The investment will be made through subscription to equity shares in one or more tranches starting from the financial year 2026–27.
This capital infusion is aimed at strengthening the financial position of its overseas business and supporting long-term growth initiatives, particularly in Europe and Southeast Asia.
Acquisition in Healthcare Sector
Marking a strategic diversification, Tata Steel also approved the acquisition of a substantial stake in Medica TS Hospital Private Limited from Manipal Hospitals Eastern India Private Limited.
The acquisition, valued at approximately Rs 1.49 crore, includes:
* 7,40,000 equity shares representing a 49% stake
* 2,30,05,182 optionally convertible redeemable preference shares, accounting for 31.85 % of the preference shareholding.
Upon completion of the transaction, Medica TS Hospital will become a wholly owned subsidiary of Tata Steel.
The move underscores the company’s intent to expand its footprint beyond core steel operations and strengthen its presence in the healthcare sector.
Regulatory Compliance and Timeline
All decisions have been made in compliance with Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board meeting commenced at 2:00 PM and concluded at 5:15 PM.
The company confirmed that detailed disclosures and annexures related to these decisions have been made available on its official website.
These strategic initiatives highlight Tata Steel’s multi-pronged growth approach—combining consolidation, global investment, and sectoral diversification—to reinforce its position as a leading multinational enterprise.
